Oh Jagyeong, Liu Yongchao, Choi Namjeong, Ha Jiyeon, Pradella Davide, Ghigna Claudia, Zheng Xuexiu, Shen Haihong
School of life Sciences, Gwangju Institute of Science and Technology, Gwangju 500-712, Korea.
Istituto di Genetica Molecolare Luigi Luca Cavalli Sforza-Consiglio Nazionale delle Ricerche Via Abbiategrasso 207, 27100 Pavia, Italy.
Cancers (Basel). 2020 Oct 30;12(11):3195. doi: 10.3390/cancers12113195.
CD44 is a transmembrane glycoprotein involved in cell-cell and cell-matrix interactions. Several CD44 protein isoforms are generated in human through alternative splicing regulation of nine variable exons encoding for the extracellular juxta-membrane region. While the CD44 splicing variants have been described to be involved in cancer progression and development, the regulatory mechanism(s) underlying their production remain unclear. Here, we identify Tra2β and SRSF9 as proteins with opposite roles in regulating CD44 exon v10 splicing. While Tra2β promotes v10 inclusion, SRSF9 inhibits its inclusion. Mechanistically, we found that both proteins are able to target v10 exon, with GAAGAAG sequence being the binding site for Tra2β and AAGAC that for SRSF9. Collectively, our data add a novel layer of complexity to the sequential series of events involved in the regulation of CD44 splicing.
CD44是一种参与细胞间和细胞与基质相互作用的跨膜糖蛋白。通过对编码细胞外近膜区域的9个可变外显子进行可变剪接调控,人类产生了几种CD44蛋白异构体。虽然CD44剪接变体已被描述与癌症进展和发展有关,但其产生的调控机制仍不清楚。在这里,我们确定Tra2β和SRSF9在调节CD44外显子v10剪接中具有相反的作用。Tra2β促进v10的包含,而SRSF9抑制其包含。从机制上讲,我们发现这两种蛋白都能够靶向v10外显子,GAAGAAG序列是Tra2β的结合位点,而AAGAC是SRSF9的结合位点。总的来说,我们的数据为CD44剪接调控所涉及的一系列连续事件增加了一层新的复杂性。